Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Ritlecitinib is an effective new treatment for Alopecia Areata.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

C-reactive protein helps monocytes stick to blood vessel cells by causing oxidative stress.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Changes in hair follicle structure may help diagnose and monitor alopecia.

The enzyme Dgat1 is essential for healthy hair and skin by controlling retinoid levels.

A new protein, mK6irs, is found in specific hair layers and may help understand hair growth and diseases.

Cystatin M/E strongly inhibits cathepsin V and cathepsin L, important for skin formation.

Reptile skin hardens by layering beta-proteins on keratin.

DPR can cause skin, hair, and nail issues, sometimes appearing later in life.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Cortisol increases a specific protein in bone cells, which may help explain its negative effects on bone.

The new model helps understand and develop treatments for genetic skin disorders like AEC.